Left Ventricular Hypertrophy and Obesity: Only a Matter of Fat?

详细信息    查看全文

• 作者：Giuseppe Murdolo ; Fabio Angeli…
• 关键词：Adipose tissue ; Concentric left ; ventricular hypertrophy ; Eccentric left ; ventricular hypertrophy ; Epicardial fat ; Hypertension ; Insulin ; resistance ; Left ; ventricular mass ; Obesity
• 刊名：High Blood Pressure & Cardiovascular Prevention
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：22
• 期：1
• 页码：29-41
• 全文大小：770 KB
• 参考文献：1. WHO Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organisation; 1998.
  2. NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956-1.
  3. Calle, EE, Thun, MJ, Petrelli, JM, Rodriguez, C, Heath, CW (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 341: pp. 1097-1105
  4. Calle, EE, Rodriguez, C, Walker-Thurmond, K, Thun, MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 348: pp. 1625-1638
  5. Sjostrom, LV (1992) Mortality of severely obese subjects. Am J Clin Nutr. 55: pp. 516S-523S
  6. Gomez-Ambrosi, J, Silva, C, Galofre, JC, Escalada, J, Santos, S, Millan, D (2012) Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond). 36: pp. 286-294
  7. Kuk, JL, Ardern, CI, Church, TS, Sharma, AM, Padwal, R, Sui, X (2011) Edmonton Obesity Staging System: association with weight history and mortality risk. Appl Physiol Nutr Metab. 36: pp. 570-576
  8. Padwal, RS, Pajewski, NM, Allison, DB, Sharma, AM (2011) Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ 183: pp. E1059-E1066
  9. Iacobellis, G, Sharma, AM Cardiovascular disease and obesity. In: Williams, G, Fruhbeck, G eds. (2009) Obesity, science to practice. Wiley-Blackwell Ltd, USA, pp. 287-320
  10. Chadwick J, Mann W. The medical works of Hyppocrates. Aphorisms, sect. II 44. Springfield: Charles C Thomas Co; 1950. p. 154.
  11. Poirier, P, Giles, TD, Bray, GA, Hong, Y, Stern, JS, Pi-Sunyer, FX (2006) Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 113: pp. 898-918
  12. Despres, JP, Lemieux, I (2006) Abdominal obesity and metabolic syndrome. Nature. 14: pp. 881-887
  13. Goossens, GH (2008) The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav. 94: pp. 206-218
  14. Andersson, CX, Gustafson, B, Hammarstedt, A, Hedjazifar, S, Smith, U (2008) Inflamed adipose tissue, insulin resistance and vascular injury. Diabetes Metab Res Rev. 24: pp. 595-603
  15. Kl?ting, N, Fasshauer, M, Dietrich, A, Kovacs, P, Sch?n, M, Kern, M (2010) Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 299: pp. E506-E515
  16. Iacobellis, G, Ribaudo, MC, Zappaterreno, A, Iannucci, CV, Leonetti, F (2005) Prevalence of uncomplicated obesity in an Italian obese population. Obes Res. 13: pp. 1116-1122
  17. Calori, G, Lattuada, G, Piemonti, L, Garancini, MP, Ragogna, F, Villa, M (2011) Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care. 34: pp. 210-215
  18. Iacobellis, G (2004) True uncomplicated obesity is not related to increased left ventricular mass and systolic dysfunction. J Am Coll Cardiol. 441: pp. 2257
  19. Sun, K, Christine, M, Kusminski, M, Scherer, P (2011) Adipose tissue remodelling in obesity. J Clin Invest. 121: pp. 2094-3101
  20. Cinti, S (2012) The adipose organ at a glance. Dis Model Mech. 55: pp. 588-594
  21. Stefan, N, Kantartzis, S, Machann, J, Schick, F, Thamer, C, Ritting, K (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 168: pp. 1609-1616
  22. Lundgren, M, Svensson, M, Lindmark, S, Rendtrom, M, Ruge, T, Eriksson, JW (2007) Fat cell enlargement is an independent marker of insulin resistance and “hyperleptinemia- Diabetologia. 50: pp. 625-633
  23. Weyer, C, Foley, J, Bogardus, C, Howard, B, Ravussin, E (2000) Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance. Diabetologia. 43: pp. 1498-1506
  24. Hammarstedt, A, Jansson, PA, Wesslau, C, Yang, X, Smith, U (2003) Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem Biophys Res Commun. 301: pp. 578-582
  25. Dubois, SG, Heilbronn, LK, Smith, SR, Albu, JB, Kelley, DE, Ravussin, E (2006) Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity (Silver Spring). 14: pp. 1543-1552
  26. Tienen, FH, Kallen, CJ, Lindsey, PJ, Wanders, RJ, Greevenbroek, MM, Smeets, HJ (2011) Preadipocytes of type 2 diabetes subjects display an intrinsic gene expression profile of decreased differentiation capacity. Int J Obes (Lond). 35: pp. 1154-1164
  27. Wang, MY, Grayburn, P, Chen, S, Rava
• 刊物主题：Cardiology; Pharmacotherapy;
• 出版者：Springer International Publishing
• ISSN：1179-1985

文摘

Obesity can be regarded as an energy balance disorder in which inappropriate expansion and dys-function of adipose tissue lead to unfavorable outcomes. Even in the absence of hypertension, adiposity induces structural and functional changes in the heart through hemodynamic and non hemodynamic factors. In the “obese-heart, besides the growth of cardiomyocytes, interstitial fat infiltration and triglyceride accumulation in the contractile elements importantly contribute to left-ventricular mass (LVM) accrual, hypertrophy (LVH) and geometric pattern. In harmony with this, the likelihood of LVH is greater in either obese normotensive or hypertensive individuals than in their non-obese counterparts. Interestingly, recent observations highlight the increasing prevalence of the “concentric-(ie, combined remodeling and hypertrophy), rather than “eccentric-pattern of LV geometry in obesity. Nonetheless, obesity is linked with lack of decrease, or even increase, of LVM over time, independently of blood pressure control and hypertensive treatment. Although obesity-related LV changes result in progressive systolic and diastolic heart failure, the assessment of LVM and LVH in obese individuals still remains a difficult task. In this scenario, it is tempting to speculate that therapeutic interventions for reversal of LVH in obesity should either overcome the “non-hemodynamic-factors or reduce the hemodynamic load. Indeed, weight loss, either achieved by lifestyle changes or bariatric procedures, decreases LVM and improves LV function regardless of blood pressure status. These and other mechanistic insights are discussed in this review, which focuses on “adipose dysfunction-as potential instigator of, and putative therapeutic target for, LVH regression in the setting of obesity.